These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 19225570)
1. Protection against retrovirus pathogenesis by SR protein inhibitors. Keriel A; Mahuteau-Betzer F; Jacquet C; Plays M; Grierson D; Sitbon M; Tazi J PLoS One; 2009; 4(2):e4533. PubMed ID: 19225570 [TBL] [Abstract][Full Text] [Related]
2. Deletion of the N-terminus of SF2/ASF permits RS-domain-independent pre-mRNA splicing. Shaw SD; Chakrabarti S; Ghosh G; Krainer AR PLoS One; 2007 Sep; 2(9):e854. PubMed ID: 17786225 [TBL] [Abstract][Full Text] [Related]
3. IFITM3 Reduces Retroviral Envelope Abundance and Function and Is Counteracted by glycoGag. Ahi YS; Yimer D; Shi G; Majdoul S; Rahman K; Rein A; Compton AA mBio; 2020 Jan; 11(1):. PubMed ID: 31964738 [TBL] [Abstract][Full Text] [Related]
4. Protection against retroviral diseases after vaccination is conferred by interference to superinfection with attenuated murine leukemia viruses. Corbin A; Sitbon M J Virol; 1993 Sep; 67(9):5146-52. PubMed ID: 8394442 [TBL] [Abstract][Full Text] [Related]
5. HIV Rev-dependent binding of SF2/ASF to the Rev response element: possible role in Rev-mediated inhibition of HIV RNA splicing. Powell DM; Amaral MC; Wu JY; Maniatis T; Greene WC Proc Natl Acad Sci U S A; 1997 Feb; 94(3):973-8. PubMed ID: 9023367 [TBL] [Abstract][Full Text] [Related]
7. Differential effects of the SR proteins 9G8, SC35, ASF/SF2, and SRp40 on the utilization of the A1 to A5 splicing sites of HIV-1 RNA. Ropers D; Ayadi L; Gattoni R; Jacquenet S; Damier L; Branlant C; Stévenin J J Biol Chem; 2004 Jul; 279(29):29963-73. PubMed ID: 15123677 [TBL] [Abstract][Full Text] [Related]
8. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506. Pilch B; Allemand E; Facompré M; Bailly C; Riou JF; Soret J; Tazi J Cancer Res; 2001 Sep; 61(18):6876-84. PubMed ID: 11559564 [TBL] [Abstract][Full Text] [Related]
9. Selective modification of alternative splicing by indole derivatives that target serine-arginine-rich protein splicing factors. Soret J; Bakkour N; Maire S; Durand S; Zekri L; Gabut M; Fic W; Divita G; Rivalle C; Dauzonne D; Nguyen CH; Jeanteur P; Tazi J Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8764-9. PubMed ID: 15939885 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of essential splicing factor ASF/SF2 blocks the temporal shift in adenovirus pre-mRNA splicing and reduces virus progeny formation. Molin M; Akusjärvi G J Virol; 2000 Oct; 74(19):9002-9. PubMed ID: 10982344 [TBL] [Abstract][Full Text] [Related]
11. Evidence for the function of an exonic splicing enhancer after the first catalytic step of pre-mRNA splicing. Chew SL; Liu HX; Mayeda A; Krainer AR Proc Natl Acad Sci U S A; 1999 Sep; 96(19):10655-60. PubMed ID: 10485881 [TBL] [Abstract][Full Text] [Related]
12. SR proteins Asf/SF2 and 9G8 interact to activate enhancer-dependent intron D splicing of bovine growth hormone pre-mRNA in vitro. Li X; Shambaugh ME; Rottman FM; Bokar JA RNA; 2000 Dec; 6(12):1847-58. PubMed ID: 11142383 [TBL] [Abstract][Full Text] [Related]
13. SR protein splicing factors interact with the Rous sarcoma virus negative regulator of splicing element. McNally LM; McNally MT J Virol; 1996 Feb; 70(2):1163-72. PubMed ID: 8551577 [TBL] [Abstract][Full Text] [Related]
14. An RNA splicing enhancer-like sequence is a component of a splicing inhibitor element from Rous sarcoma virus. McNally LM; McNally MT Mol Cell Biol; 1998 Jun; 18(6):3103-11. PubMed ID: 9584151 [TBL] [Abstract][Full Text] [Related]
15. Exonic splicing enhancer-dependent selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site can be rescued in a cell lacking splicing factor ASF/SF2 through activation of the phosphatidylinositol 3-kinase/Akt pathway. Liu X; Mayeda A; Tao M; Zheng ZM J Virol; 2003 Feb; 77(3):2105-15. PubMed ID: 12525645 [TBL] [Abstract][Full Text] [Related]
16. Genetic analysis of the SR protein ASF/SF2: interchangeability of RS domains and negative control of splicing. Wang J; Xiao SH; Manley JL Genes Dev; 1998 Jul; 12(14):2222-33. PubMed ID: 9679066 [TBL] [Abstract][Full Text] [Related]
17. Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins. Zhu J; Mayeda A; Krainer AR Mol Cell; 2001 Dec; 8(6):1351-61. PubMed ID: 11779509 [TBL] [Abstract][Full Text] [Related]
18. Balanced splicing at the Tat-specific HIV-1 3'ss A3 is critical for HIV-1 replication. Erkelenz S; Hillebrand F; Widera M; Theiss S; Fayyaz A; Degrandi D; Pfeffer K; Schaal H Retrovirology; 2015 Mar; 12():29. PubMed ID: 25889056 [TBL] [Abstract][Full Text] [Related]
19. Substrate specificities of SR proteins in constitutive splicing are determined by their RNA recognition motifs and composite pre-mRNA exonic elements. Mayeda A; Screaton GR; Chandler SD; Fu XD; Krainer AR Mol Cell Biol; 1999 Mar; 19(3):1853-63. PubMed ID: 10022872 [TBL] [Abstract][Full Text] [Related]
20. Novel exploitation of a nuclear function by influenza virus: the cellular SF2/ASF splicing factor controls the amount of the essential viral M2 ion channel protein in infected cells. Shih SR; Krug RM EMBO J; 1996 Oct; 15(19):5415-27. PubMed ID: 8895585 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]